Paper32739773
SiO2-coated magnetic nano-Fe3O4 photosensitizer for synergistic tumour-targeted chemo-photothermal therapy.
Dai Z and 7 others. Colloids Surf B Biointerfaces, 2020. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. SiO2-coated magnetic nano-Fe3O4 photosensitizer for synergistic tumour-targeted chemo-photothermal therapy. Papers, record 32739773. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32739773
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- SiO2-coated magnetic nano-Fe3O4 photosensitizer for synergistic tumour-targeted chemo-photothermal therapy.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hyperthermia, Induced | Major topic |
| Neoplasms | Major topic |
| Photosensitizing Agents | Major topic |
| Doxorubicin | |
| Humans | |
| Magnetic Phenomena | |
| Nanoparticles | |
| Phototherapy | |
| Photothermal Therapy | |
| Silicon Dioxide |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40370857 | Magnetic mesoporous silica nanoparticles as advanced polymeric scaffolds for efficient cancer chemotherapy: recent progress and challenges. | RSC Adv | 2025 | https://conductscience.org/library/papers/40370857 | PubMed |
| 40281731 | Micron-Sized Fe3O4/PCL Biocomposite Scaffolds to Attract Magnetic Nanoparticles for Targeted Drug Delivery. | Bioengineering (Basel) | 2025 | https://conductscience.org/library/papers/40281731 | PubMed |
| 39713612 | Magnetic Nanocarriers for pH/GSH/NIR Triple-Responsive Drug Release and Synergistic Therapy in Tumor Cells. | ACS Omega | 2024 | https://conductscience.org/library/papers/39713612 | PubMed |
| 39604129 | Effect of Transferrin-Modified Fe3O4 Nanoparticle Targeted Delivery miR-15a-5p Combined With Photothermal Therapy on Lung Cancer. | Thorac Cancer | 2025 | https://conductscience.org/library/papers/39604129 | PubMed |
| 37130996 | Design of an imaging magnetic microsphere based on photopolymerization for magnetic hyperthermia in tumor therapy. | Drug Deliv Transl Res | 2023 | https://conductscience.org/library/papers/37130996 | PubMed |
| 36903753 | Smart Magnetic Drug Delivery Systems for the Treatment of Cancer. | Nanomaterials (Basel) | 2023 | https://conductscience.org/library/papers/36903753 | PubMed |
| 36365090 | Effect of the Silica-Magnetite Nanocomposite Coating Functionalization on the Doxorubicin Sorption/Desorption. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/36365090 | PubMed |
| 34834387 | Smart Nanotherapeutics and Lung Cancer. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/34834387 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32739773
GET https://conductscience.org/api/papers/v1/32739773/authors